Financhill
Sell
29

CHRS Quote, Financials, Valuation and Earnings

Last price:
$1.21
Seasonality move :
0.05%
Day range:
$1.18 - $1.27
52-week range:
$0.71 - $1.89
Dividend yield:
0%
P/E ratio:
1.06x
P/S ratio:
1.66x
P/B ratio:
1.65x
Volume:
1M
Avg. volume:
1.3M
1-year change:
-20.53%
Market cap:
$145M
Revenue:
$267M
EPS (TTM):
-$1.59

Earnings Data

Next earnings date for CHRS
Mar 10
2026
Most recent earnings per share
-$0.30
Missed by $0.01
(Nov 6/2025)
Consensus Estimate
-$0.29
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CHRS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/10/2026 Q4 $14.4M -- -- -$0.31 --
11/06/2025 Q3 $13.4M $11.6M -$0.30 -$0.29 -$0.01
08/07/2025 Q2 $9.3M $10.3M -$0.36 -$0.27 -$0.08
05/08/2025 Q1 $54.7M $7.6M -$0.49 -$0.22 -$0.27
03/10/2025 Q4 $43.9M $54.1M -$0.44 -$0.13 -$0.31
11/06/2024 Q3 $56.8M $70.8M -$0.09 -$0.11 $0.02
08/08/2024 Q2 $56.4M $65M -$0.11 -$0.26 $0.15
05/09/2024 Q1 $83.7M $77.1M $0.83 -$0.21 $1.04
03/13/2024 Q4 $90.4M $91.5M -$0.71 -$0.10 -$0.61
11/06/2023 Q3 -- -- -$0.41 -$0.24 -$0.17
08/02/2023 Q2 -- -- -$0.49 -$0.44 -$0.05
05/08/2023 Q1 -- -- -$0.96 -$0.47 -$0.49
03/06/2023 Q4 -- -- -$0.76 -$0.69 -$0.07
11/08/2022 Q3 -- -- -$1.11 -$0.61 -$0.50
08/04/2022 Q2 -- -- -$0.65 -$0.73 $0.08
05/05/2022 Q1 -- -- -$1.24 -$0.65 -$0.59
02/17/2022 Q4 -- -- -$0.60 -$0.54 -$0.06
11/08/2021 Q3 -- -- -$0.49 -$0.29 -$0.20
08/05/2021 Q2 -- -- -$0.40 -$0.15 -$0.25
05/06/2021 Q1 -- -- -$2.37 $0.11 -$2.48
02/24/2021 Q4 -- -- $0.12 $0.27 -$0.15
11/05/2020 Q3 -- -- $0.33 $0.34 -$0.01
08/06/2020 Q2 -- -- $0.70 $0.29 $0.41
05/07/2020 Q1 -- -- $0.48 $0.48 $0.01
02/27/2020 Q4 -- -- $0.53 $0.70 -$0.17
11/06/2019 Q3 -- -- $0.63 $0.42 $0.21
08/01/2019 Q2 -- -- -- -$0.04 --
05/09/2019 Q1 -- -- -- -$0.46 --
02/28/2019 Q4 -- -- -- -$0.84 --
11/08/2018 Q3 -- -- -- -$0.79 --
08/08/2018 Q2 -- -- -- -$0.65 --
05/10/2018 Q1 -- -- -- -- --
03/08/2018 Q4 -- -- -- -- --
11/06/2017 Q3 -- -- -- -- --
08/07/2017 Q2 -- -- -- -- --
05/08/2017 Q1 -- -- -- -- --
03/13/2017 Q4 -- -- -- -- --
11/09/2016 Q3 -- -- -- -- --
08/09/2016 Q2 -- -- -- -- --
05/09/2016 Q1 -- -- -- -- --
02/29/2016 Q4 -- -- -- -- --

Coherus Oncology, Inc. Earnings Questions

  • How Much did Coherus Oncology, Inc. Generate in Revenue Last Quarter?

    Coherus Oncology, Inc. reported $11.6M worth of top line sales in its most recent quarter.

  • Did Coherus Oncology, Inc. Beat Earnings Last Quarter?

    Coherus Oncology, Inc. announced earnings per share of -$0.30 which represents a miss of analyst forecast a -$0.29 per share.

  • Is Coherus Oncology, Inc. Profitable?

    Coherus Oncology, Inc. reported $6.9M that represents $0.06 per share over the last quarter.

  • What is the Analyst Consensus for Coherus Oncology, Inc. EPS Next Year?

    Coherus Oncology, Inc.'s earnings are forecast to decrease from $0.25 per share to -$0.86 per share next year representing a decrease of -97.41%.

  • When is Coherus Oncology, Inc.'s Earnings Date?

    Coherus Oncology, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock